MedTrace Logo

Role of Magnetic Resonance Enterography for Predicting Peritoneal Cancer Index

NCT05063019 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2021-10-18

No results posted yet for this study

Summary

This is a prospective observational study which will recruit 90 participants over a three-year period to investigate whether adding magnetic resonance imaging and enterography to routine computed tomography study can better predict the extend of peritoneal carcinomatosis over computed tomography alone.

Conditions

  • Hyperthermic Intraperitoneal Chemotherapy
  • Cytoreductive Surgery
  • Peritoneal Carcinomatosis

Interventions

DIAGNOSTIC_TEST

MRI

Magnetic resonance imaging and enterography before surgery

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Principal Investigators

  • Chia-Ni Lin, MA · Chang Gung Memorial Hospital, Chiayi, Taiwan

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05063019 on ClinicalTrials.gov